|
|
||||||||
AJP - Renal Physiology, Vol 264, Issue 3 532-F539, Copyright © 1993 by American Physiological Society
ARTICLES |
W. F. Glass 2nd, J. I. Kreisberg and D. A. Troyer
Audie L. Murphy Memorial Veterans Hospital, Department of Pathology, University of Texas Health Science Center, San Antonio 78284.
Urokinase-type plasminogen activator (u-PA), its receptor (u-PAR), and type 1 inhibitor (PAI-1) in cultured human mesangial cells were investigated. Treatment with phospholipase C (PLC) released plasminogen activators [with relative mol wt (M(r)) of 55,000 and 100,000] and u-PAR into the culture medium. By Western blot, both u-PA and PAI-1 were present in the M(r) 100,000 band. Since PAI-1 binds only active, two-chain u-PA (tcu-PA), formation of the M(r) 100,000 band reflects conversion of the single-chain, proenzyme form of u-PA (scu-PA) to tcu-PA. Immunofluorescence staining of whole cells demonstrated the presence of PAI-1, u-PA, and u-PAR. Immunofluorescence staining and Western blot analysis showed enrichment of PAI-1, u-PA, and u-PAR in a preparation of substratum-attached extracellular matrix and membrane proteins termed adhesion plaques. Using a chromogenic assay, we found that PAI-1 expression in adhesion plaques exceeded that of u-PA. We conclude that cultured human mesangial cells produce receptor-bound u-PA/PAI-1 complexes localized to adhesion plaques.
This article has been cited by other articles:
![]() |
C. Y. Song, B. C. Kim, H. K. Hong, B. K. Kim, Y. S. Kim, and H. S. Lee Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells Am J Physiol Renal Physiol, September 1, 2002; 283(3): F423 - F430. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |